Cervical, vaginal and vulvar intraepithelial neoplasms;Intraepitelijalne neoplazme grlića materice, vagine i vulve

Vojnosanitetski Pregled

Volumn 68, Issue 12, 2011, Pages 1051-1056

  Mitrović Jovanović, Ana ^a   Stanimirović, Branko ^a   Nikolić, Branka ^a   Zamurović, Milena ^a   Perišić, Živko ^a   Pantić Aksentijevic, Snežana ^b  

^a University Clinic of Gynecology and Obstetrics 'Narodni front'   (Serbia)

^b Ministry of Health of the Republic of Serbia   (Serbia)

Author keywords

Cervical intraepithelial neoplasia; Diagnostic techniques and procedures; Prognosis; Risk factors; Therapeutics; Vaccination; Vaginal neoplasms

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; FLUOROURACIL; IMIQUIMOD; INTERFERON;

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CAUTERIZATION; COLD TREATMENT; CRYOTHERAPY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HUMAN; LASER COAGULATION; POSTOPERATIVE PERIOD; PROGNOSIS; REVIEW; RISK FACTOR; SYMPTOMATOLOGY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; VAGINAL INTRAEPITHELIAL NEOPLASIA; VULVA CANCER; VULVAR INTRAEPITHELIAL CANCER;

CARCINOMA IN SITU; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 82955190588     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1112051M     Document Type: Review

References (31)

1. Vaccarella S, Franceschi S, Snijders PJ, Herrero R, Meijer CJ, Plummer M. Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2010; 19(2): 503-10.
2. Munoz N, Bosch FX, de Sanjose S Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348(6): 518-27.
3. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005; 191(2): 182-92.
4. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA 2007; 297(8): 813-9.
5. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338(7): 423-8.
6. Castellsagué X, Díaz M, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and preventions. J Natl Cancer Inst 2006; 98(5): 303-15.
7. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer 2007; 121(3): 621-32.
8. Gavillon N, Vervaet H, Derniaux E, Terrosi P, Graesslin O, Quereux C. How did I contract human papillomavirus (HPV)? Gynecol Obstet Fertil 2010; 38(3): 199-204. (French)
9. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55(4): 244-65.
10. Smith HO, Tiffany MF, Qualls CR Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the Unated States-a 24-year populationbased study. Gynecol Oncol 2000; 78(2): 97-105.
11. Stanimirović B, Antić N, Kuljić-Kapulica N, Vasiljević M, Marković A, Stanimirović V. Effect of certain aspects of female sexual behavior on the development of cervical intraepithelial neoplasia. Srp Arh Celok Lek 2000; 128(11-12): 374-8. (Serbian)
12. Illades-Aguiar B, Alarcón-Romero Ldel C, Antonio-Véjar V, Zamudio-López N, Sales-Linares N, Flores-Alfaro E, et al. Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico. Gynecol Oncol 2010; 117(2): 291-6.
13. Su JH, Wu A, Scotney E, Ma B, Monie A, Hung CF, et al. Immunotherapy for cervical cancer: research status and clinical potential. Bio Drugs 2010; 24(2):109-29.
14. Stojanović J, Magić Z, Milacić M, Nenadić D, Stanimirović B, Vukicević D. Distribution of high-risk HPV types in Yugoslav women with cervical neoplasia. J BUON 2002; 7(3): 251-6.
15. Ikenberg H, Teufel G, Schmitt B, Kommoss F, Stanimirovic B, Pfleiderer A. Human papillomavirus DNA in distant metastases of cervical cancer. Gynecol Oncol 1993; 48(1): 56-60.
16. Constandinou-Williams C, Collins SI, Roberts S, Young LS, Woodman CB, Murray PG. Is human papillomavirus viral load a clinically useful predictive marker? Cancer Epidemiol Biomarkers Prev 2010; 19(3): 832-7.
17. Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, Sherman ME, et al. Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst 2010; 102(5): 315-24.
18. Stanimirović B, Kovacević Z. The national program for the early detection and treatment of premalignant and malignant diseases of the lower genital system in women. Srp Arh Celok Lek 1997; 125(5-6): 181-4. (Serbian)
19. Stanimirović B, Kuljić-Kapulica N, Popović-Lazić J, Stanimirovic V, Vasiljevic M. Detection of human papillomaviruses in cervical intraepithelial neoplasms. Srp Arh Celok Lek 2000; 128(11-12): 370-3. (Serbian)
20. Stanimirović B, Grob R, Rüdlinger R. Carcinoma of the cervix uteri and risk factors. Eur J Gynaecol Oncol 1990; 11(1): 51-6.
21. Krajinovic M, Lazic J, Stanimirovic B, Diklic V, Savic A. The E2 region of HPV 16 in relation to different types of cervical lesions. J Med Virol 1993; 41(1): 1-5.
22. Word Health Organisation. Human Papillomavirus and HPV vaccines: technical information for policy-makers and health professionals. Initiative for Vaccine Research. Switzerland, Geneva: WHO; 2007.
23. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2): 74-108.
24. Word Health Organisation. Cervical cancer, human papillomavirus (HPV) and HPV vaccines Key points for policy-markers and health professionals. Switzerland, Geneva: WHO; 2007.
25. Republic Expert Committee on the Preparation and Implementation of Guidlines for Primary Health Care Physicians. Prevention of malignant diseases. Belgrade: Ministarstvo zdravlja Republike Srbije, Srpsko lekarsko društvo; 2005; 11: 27-44.
26. Franco EL, Harper DM. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccinae 2005; 23(17-18): 2388-94.
27. Huang CF, Monie A, Weng WH, Wu T. DNA vaccines for cervical cancer. Am J Transl Res 2010; 2(1): 75-87.
28. Logani S, Lu D, Quint W, Ellenson L, Pirog EC. Low grade vulvar and vaginal intraepithelial neoplasia: correlation of histologic features with Human Papillomavirus DNA detection and MIB-1 immunostaining. Mod Pathol 2003; 16(8): 735-41.
29. Hellman K, Silfverswärd C, Nilsson B, Hellström AC, Frankendal B, Pettersson F. Primary carcinoma of the vagina: factors influencing the age at diagnosis. The radiumhemmet series 1956-96. Int J Gynecol Cancer 2004; 14(3): 491-501.
30. van Seters M, van Beurden M, ten Kate FJ, Beckmann I, Ewing PC, Eijkemans MJ, et al. Treatment of vulvar intraepithelial neoplasia with topical imiquimod. N Engl J Med 2008; 358(14): 1465-73.
31. Ordi J, Alejo M, Fuste V, Lloveras B, Del Pino M, Alonso I, et al. HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simpex (differentiated) VIN. Am J Surg Pathol 2009; 33(11): 1659-65.